SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Masi G. Expert Opin. Pharmacother. 2005; 6(4): 547-560.

Copyright

(Copyright © 2005, Informa - Taylor and Francis Group)

DOI

10.1517/14656566.6.4.547

PMID

15934881

Abstract

Awareness of bipolar spectrum disorders in children is rapidly increasing, with a more precise definition of their clinical subtypes and early signs. Paediatric bipolar disorder can lead to an important impairment in scholastic, familial and social functioning, and to a higher risk for substance abuse and suicide. In the context of a multimodal approach, the core treatment of early-onset bipolar disorder is pharmacological. This review focuses on the empirical evidence for pharmacotherapy in paediatric bipolar disorder. Mood stabilizers, including lithium, and older and newer anticonvulsivants will be considered, in mono- or polypharmacy. Atypical antipsychotics will be considered in more severe and/or treatment-resistant manic or mixed episodes. Finally, the prophylaxis of intercritical phases and the management of specific challenging conditions, such as bipolar depression and attention deficit hyperactivity disorder, with bipolar comorbidity, will be reviewed.


Language: en

Keywords

Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Puberty

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print